Difference between revisions of "Lung Density Biomarker Ctte"

From QIBA Wiki
Jump to: navigation, search
m (Recent Meetings/Call Summaries)
m (Recent Meetings/Call Summaries)
Line 16: Line 16:
 
==Recent Meetings/Call Summaries==
 
==Recent Meetings/Call Summaries==
  
 +
*[[Media:04 22 2020 QIBA CT Lung Density BC Call Summary-FINAL.pdf|April 22, 2020]]
 
*[[Media:03 11 2020 QIBA CT Lung Density BC Call Summary-FINAL.pdf|March 11, 2020]]
 
*[[Media:03 11 2020 QIBA CT Lung Density BC Call Summary-FINAL.pdf|March 11, 2020]]
 
*[[Media:01 22 2020 QIBA CT Lung Density BC Call Summary-FINAL.pdf|January 22, 2020]]
 
*[[Media:01 22 2020 QIBA CT Lung Density BC Call Summary-FINAL.pdf|January 22, 2020]]

Revision as of 16:19, 28 April 2020

Co-chairs: Sean Fain, PhD; Charles Hatt, PhD; David Lynch, MD
RSNA Staff Support: Julie Lisiecki

Scope

Scope: Quantitative CT lung densitometry and morphology for COPD and related diseases.

Initial Objectives:

  • Characterize the precision and accuracy of phenotyping and progression measurements in emphysema and asthma.
This is an essential effort to classify phenotype and assess longitudinal changes as medically meaningful surrogates for health status.
  • Compare the sensitivity of CT measurements to spirometry and other accepted measures.
This will be necessary in order to determine if Progressive Disease can be detected significantly sooner with quantitative imaging techniques than with currently accepted methods.

Recent Meetings/Call Summaries


See archive for 2019 and earlier summaries

Lung Density/COPD BC Call Summaries Archive

Profile Development

Status - <summarize current status>

Archive - Lung Density

Protocol Development Activities


Groundwork Activities

Validate key concepts and answer key questions needed to write the Profiles and demonstrate their effectiveness.

  • Phantom project


Working Documents


Reference Documents


QIBA Funded Projects

Round 2

Round 4

Round 5

Round 6